Catheter Precision announced additional product evaluations for its newest product, LockeT. As previously announced, the company has recently expanded their US sales and clinical team in preparation for the national product launch of LockeT.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision receives new purchase order, product evaluation at hospital
- Catheter Precision appoints Marie-Claude Jacques as CCO
- Catheter Precision receives first purchase order for LockeT from HCA Healthcare
- Catheter Precision price target lowered to $4.10 from $7 at Ladenburg
- Catheter Precision expects cash flow break even by end of calendar year